Event - Today
Erin James, University of Sussex's 'Stuart Hall Fellow', to perform at Brighton Festival
Erin James, University of Sussex's 'Stuart Hall Fellow', to perform at Brighton Festival
Innovation - Today
National Grid and University of Manchester pilot drone-mounted electric field sensors for pylon inspections
National Grid and University of Manchester pilot drone-mounted electric field sensors for pylon inspections
wire
« BACK
Health - Pharmacology - 09.06.2021
Health - Pharmacology - 08.06.2021 
RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19
The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for patients hospitalised with COVID-19.
Health - Pharmacology - 07.06.2021 
Alternative treatments to combat drug-resistant bacteria focus of major new study
The growing challenge of Antimicrobial Resistance (AMR), where germs like bacteria and fungi develop the ability to defeat the drugs designed to kill them, is at the heart of a new funding collaboration involving UCL researchers.
Health - Pharmacology - 04.06.2021 
Pfizer-BioNTech vaccine recipients have lower antibody levels targeting the Delta variant
Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are, on average, lower than those against variants previously circulating in the UK, finds a new study involving UCL.
Health - Pharmacology - 01.06.2021 
Immunity experts move into state-of-the-art facilities
Scientists at UCL are preparing to move into a new ultra-modern research facility which will enable them to work more closely with clinicians to develop revolutionary treatments and cures for some of the most devastating diseases of the immune system.
Health - Pharmacology - 26.05.2021
Life Sciences - Pharmacology - 26.05.2021
Health - Pharmacology - 25.05.2021
Health - Pharmacology - 20.05.2021
Health - Pharmacology - 19.05.2021
Pharmacology - Health - 14.05.2021 
Clinical trial co-led by UCL leads to new bowel cancer drug approval
Cancer researchers at UCL, involved in an international trial which found that pembrolizumab more than doubled the 'progression free survival' of patients with a subtype of bowel cancer, when compared with chemotherapy, are delighted it has now been approved by the UK regulator.
Health - Pharmacology - 14.05.2021
Pharmacology - Health - 12.05.2021 
Personalised pacemakers could help heart patients keep fit
People living with heart failure could benefit from personalised pacemakers to help them exercise safely, thanks to a trial being carried out by a team in the School of Medicine.
Health - Pharmacology - 11.05.2021
Health - Pharmacology - 11.05.2021
Health - Pharmacology - 11.05.2021 
Study investigates immune response to Covid-19 in patients with antibody deficiency
How the immune systems of patients with antibody deficiency respond to SARS-CoV-2 infection and vaccination will be investigated as part of a new national study co-led by UCL researchers.
Health - Pharmacology - 11.05.2021
Health - Pharmacology - 10.05.2021
Health - Pharmacology - 06.05.2021
Pharmacology - Health - 06.05.2021 
Only 41% of people would sign up for COVID-19 trials says new report by the University of Birmingham
Research conducted by the University of Birmingham shows in order to have an effective Covid-19 vaccination rollout it has to be widely accepted to the entire population.
Pharmacology - Health - 05.05.2021 
To radically improve the delivery of chemotherapy treatment
New scheduling model improves patient waiting times by 80% and cuts nurse overtime by more than 30% Last updated on Thursday 6 May 2021 A new study from the University of Bath School of Management, T
Pharmacology - Health - 29.04.2021
Pharmacology - Health - 28.04.2021
Health - Pharmacology - 26.04.2021
Pharmacology - Social Sciences - 19.04.2021
Health - Pharmacology - 16.04.2021
Health - Pharmacology - 15.04.2021
Health - Pharmacology - 14.04.2021
Health - Pharmacology - 14.04.2021
Health - Pharmacology - 13.04.2021
Health - Pharmacology - 13.04.2021 
Newly launched British biotech company pioneers ground-breaking potential treatments for COVID-19
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and newly patented potential treatments for coronavirus.
Health - Pharmacology - 13.04.2021
Health - Pharmacology - 12.04.2021
Health - Pharmacology - 12.04.2021 
Weather forecasts that predict meningitis outbreaks
Scientists are using weather forecasts to predict the location and scale of impending meningitis outbreaks in sub-Saharan Africa. It is part of an early-warning system being piloted with the aim of giving health agencies more time to activate emergency response plans.
Pharmacology - 09.04.2021
Health - Pharmacology - 07.04.2021
Health - Pharmacology - 07.04.2021
Health - Pharmacology - 07.04.2021
Health - Pharmacology - 01.04.2021
Pharmacology - Politics - 31.03.2021
Pharmacology - Health - 30.03.2021
Career - Pharmacology - 30.03.2021
Pharmacology - Health - 29.03.2021
Pharmacology - Health - 29.03.2021
Health - Pharmacology - 26.03.2021
Health - Pharmacology - 25.03.2021 
New partnership enables access to state-of-the-art radiotherapy machine in Oxford | University of Oxford
The new ViewRay MRIdian machine is the first of its kind in the UK and will help to improve challenging cancer treatment through faster, tailored radiotherapy.
Health - Pharmacology - 25.03.2021 
Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital
A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.
Health - Pharmacology - 24.03.2021 
Patients should receive COVID-19 vaccine before surgery to reduce risk of postoperative death - study
Patients waiting for elective surgery should get COVID-19 vaccines ahead of the general population - potentially helping to avoid thousands of post-operative deaths linked to the virus, according to a new study funded by the NIHR.
Pharmacology - Health - 24.03.2021
Health - Pharmacology - 24.03.2021
Pharmacology
Results 201 - 250 of 583.
Novel UCL developed cancer drug to be trialled in humans
Patients with a number of Non-Hodgkin lymphoma (NHL) subtypes will be used to trial a novel cancer treatment developed by researchers at UCL, which holds "great promise" for several incurable conditions.
Patients with a number of Non-Hodgkin lymphoma (NHL) subtypes will be used to trial a novel cancer treatment developed by researchers at UCL, which holds "great promise" for several incurable conditions.
The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for patients hospitalised with COVID-19.
The growing challenge of Antimicrobial Resistance (AMR), where germs like bacteria and fungi develop the ability to defeat the drugs designed to kill them, is at the heart of a new funding collaboration involving UCL researchers.
Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are, on average, lower than those against variants previously circulating in the UK, finds a new study involving UCL.
Scientists at UCL are preparing to move into a new ultra-modern research facility which will enable them to work more closely with clinicians to develop revolutionary treatments and cures for some of the most devastating diseases of the immune system.
Almost half of patients with inoperable pancreatic cancer are not prescribed essential medication
A University of Birmingham-led study has found almost half of people diagnosed within inoperable pancreatic cancer are not prescribed inexpensive yet essential tablets without which they cannot digest food - placing them at risk of starvation or being less able to tolerate treatment.
A University of Birmingham-led study has found almost half of people diagnosed within inoperable pancreatic cancer are not prescribed inexpensive yet essential tablets without which they cannot digest food - placing them at risk of starvation or being less able to tolerate treatment.
Covid-19 vaccine: Common stroke symptoms must be ’urgently evaluated’
UCL and UCLH neurologists have published the first clinical observations of patients who experienced an ischaemic stroke, the most common form of stroke, following an Oxford AstraZeneca vaccine.
UCL and UCLH neurologists have published the first clinical observations of patients who experienced an ischaemic stroke, the most common form of stroke, following an Oxford AstraZeneca vaccine.
Cancer researchers at UCL, involved in an international trial which found that pembrolizumab more than doubled the 'progression free survival' of patients with a subtype of bowel cancer, when compared with chemotherapy, are delighted it has now been approved by the UK regulator.
Delaying second Pfizer vaccines to 12 weeks significantly increases antibody responses in older people, finds study
Antibody response in people aged over 80 is three-and-a-half times greater in those who have the second dose of the Pfizer COVID-19 vaccine after 12 weeks compared to those who have it at a three-week interval, finds a new study led by the University of Birmingham in collaboration with Public Health England.
Antibody response in people aged over 80 is three-and-a-half times greater in those who have the second dose of the Pfizer COVID-19 vaccine after 12 weeks compared to those who have it at a three-week interval, finds a new study led by the University of Birmingham in collaboration with Public Health England.
People living with heart failure could benefit from personalised pacemakers to help them exercise safely, thanks to a trial being carried out by a team in the School of Medicine.
Better treatment for miscarriage patients is more cost effective than current standard NHS treatment
A new drug combination that is better at treating miscarriage is also more cost effective than current standard NHS treatment, finds a new study led by the University of Birmingham and Tommy's National Centre for Miscarriage Research. A previous study by the same team and published in The Lancet in August last year, found that a combined drug treatment is more effective than the standard medication for women having miscarriages without symptoms - also known as missed, delayed or silent miscarriage.
A new drug combination that is better at treating miscarriage is also more cost effective than current standard NHS treatment, finds a new study led by the University of Birmingham and Tommy's National Centre for Miscarriage Research. A previous study by the same team and published in The Lancet in August last year, found that a combined drug treatment is more effective than the standard medication for women having miscarriages without symptoms - also known as missed, delayed or silent miscarriage.
Study launches to investigate immune response to SARS-CoV-2 infection in patients with antibody deficiencies
A new study being led by the University of Birmingham, University Hospitals Birmingham NHS Foundation Trust, and University College London aims to explore the immune response to natural COVID-19 infection and vaccination in patients with antibody deficiency.
A new study being led by the University of Birmingham, University Hospitals Birmingham NHS Foundation Trust, and University College London aims to explore the immune response to natural COVID-19 infection and vaccination in patients with antibody deficiency.
How the immune systems of patients with antibody deficiency respond to SARS-CoV-2 infection and vaccination will be investigated as part of a new national study co-led by UCL researchers.
Bayer to invest in childhood cancer trial at the University of Birmingham
Significant funding from Bayer, a global enterprise with core competencies in the life science fields of healthcare and nutrition, is enabling the University of Birmingham's Cancer Research UK Clinic
Significant funding from Bayer, a global enterprise with core competencies in the life science fields of healthcare and nutrition, is enabling the University of Birmingham's Cancer Research UK Clinic
University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb
The University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.
The University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.
Research conducted by the University of Birmingham shows in order to have an effective Covid-19 vaccination rollout it has to be widely accepted to the entire population.
New scheduling model improves patient waiting times by 80% and cuts nurse overtime by more than 30% Last updated on Thursday 6 May 2021 A new study from the University of Bath School of Management, T
Preference for AZ vaccine declines - but vaccine confidence undented
The public's preference for the AstraZeneca Covid vaccine has declined since last month, and belief that it causes blood clots has increased - but despite this, vaccine confidence is higher than it w
The public's preference for the AstraZeneca Covid vaccine has declined since last month, and belief that it causes blood clots has increased - but despite this, vaccine confidence is higher than it w
Researchers win £1.3M funding to make a portable device to detect street drug ’spice’
A portable device to detect spice is being developed at Bath. This will be the first gadget to give on-the-spot readings for the street drug.
A portable device to detect spice is being developed at Bath. This will be the first gadget to give on-the-spot readings for the street drug.
Risk of rare blood clotting higher for COVID-19 than for vaccines
COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.
COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.
Over-80s show similar antibody responses following single vaccination with either Pfizer or AstraZeneca vaccine - but cellular responses are enhanced after AstraZeneca vaccine
People aged over 80 receiving a single dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination.
People aged over 80 receiving a single dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination.
Profile: How UK doctor linked rare blood-clotting to AstraZeneca Covid jab
Professor Marie Scully (UCL Cardiovascular Science) is interviewed about her about her work identifying a new rare blood clotting syndrome linked to the AstraZeneca Covid-19 vaccine & established the correct test & treatments for patients, helping save lives.
Professor Marie Scully (UCL Cardiovascular Science) is interviewed about her about her work identifying a new rare blood clotting syndrome linked to the AstraZeneca Covid-19 vaccine & established the correct test & treatments for patients, helping save lives.
COVID-19 drug screening hub at the University of Glasgow begins work
A new COVID-19 drug screening and resistance hub in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR), has begun its vital work.
A new COVID-19 drug screening and resistance hub in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR), has begun its vital work.
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and newly patented potential treatments for coronavirus.
Artificial Intelligence used to automate assessment of Mesothelioma
Patients receiving treatment for the "asbestos cancer", Mesothelioma, are being assessed with Artificial Intelligence (AI) as part of a prototype imaging system which could revolutionise the way people with the disease are cared for.
Patients receiving treatment for the "asbestos cancer", Mesothelioma, are being assessed with Artificial Intelligence (AI) as part of a prototype imaging system which could revolutionise the way people with the disease are cared for.
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK's PRINCIPLE trial in 1,779 participants.
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK's PRINCIPLE trial in 1,779 participants.
Scientists are using weather forecasts to predict the location and scale of impending meningitis outbreaks in sub-Saharan Africa. It is part of an early-warning system being piloted with the aim of giving health agencies more time to activate emergency response plans.
Opinion: The risks of the AstraZeneca jab are so small, yet the gains are so great
Research into the potential link between the AstraZeneca Covid-19 vaccine and blood clots is urgently needed, but the benefits of the vaccine far outweigh the risks even if a causal link is established, says Professor David Werring (UCL Queen Square Institute of Neurology).
Research into the potential link between the AstraZeneca Covid-19 vaccine and blood clots is urgently needed, but the benefits of the vaccine far outweigh the risks even if a causal link is established, says Professor David Werring (UCL Queen Square Institute of Neurology).
Dual dose of the Pfizer COVID-19 vaccine elicits strong antibody immune responses in older people
A University of Birmingham-led study supported by the UK Coronavirus Immunology Consortium has found that 98% of people aged 80 or over who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response. The research involved 100 people aged 80 to 96, who were living independently, and had received the Pfizer vaccine twice at three weeks apart.
A University of Birmingham-led study supported by the UK Coronavirus Immunology Consortium has found that 98% of people aged 80 or over who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response. The research involved 100 people aged 80 to 96, who were living independently, and had received the Pfizer vaccine twice at three weeks apart.
Overwhelming public support for donating vaccines to low-income countries
A survey led by the University of Oxford has found that most people in high-income countries support donating some of their country's COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.
A survey led by the University of Oxford has found that most people in high-income countries support donating some of their country's COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.
Uncertainty on cuts to research funding risks jeopardising UK’s position as a scientific superpower
Professor David Price, UCL Vice-Provost (Research), comments on recent uncertainty about, and cuts to, research funding: "From the rapid generation of vaccines by UK scientists to the discovery of ne
Professor David Price, UCL Vice-Provost (Research), comments on recent uncertainty about, and cuts to, research funding: "From the rapid generation of vaccines by UK scientists to the discovery of ne
Researchers create online resource to optimise NHS routes for housebound vaccinations
Two engineering DPhil students from the University of Oxford have created a website for GP surgeries across the UK to optimise the delivery of Covid-19 vaccinations to the UK's 1 million housebound patients.
Two engineering DPhil students from the University of Oxford have created a website for GP surgeries across the UK to optimise the delivery of Covid-19 vaccinations to the UK's 1 million housebound patients.
Volunteers needed for study looking into whether COVID-19 and flu vaccines can be administered at the same time
Researchers at the Bristol Trials Centre (CTEU) at the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW) are leading a new study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
Researchers at the Bristol Trials Centre (CTEU) at the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW) are leading a new study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
The new ViewRay MRIdian machine is the first of its kind in the UK and will help to improve challenging cancer treatment through faster, tailored radiotherapy.
A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.
Patients waiting for elective surgery should get COVID-19 vaccines ahead of the general population - potentially helping to avoid thousands of post-operative deaths linked to the virus, according to a new study funded by the NIHR.
Over 4 in 5 people who were hesitant would now take Covid-19 vaccine
More than four in five (86%) people who were unsure or said no to a Covid-19 vaccine in December 2020 would now take one, or have already been vaccinated, finds the latest research by UCL's Virus Watch study. Published today, the new findings, part of UCL Virus Watch's longitudinal study of over 46,000 people in England and Wales, show the fall in vaccine hesitancy was consistent across all ethnic groups.
More than four in five (86%) people who were unsure or said no to a Covid-19 vaccine in December 2020 would now take one, or have already been vaccinated, finds the latest research by UCL's Virus Watch study. Published today, the new findings, part of UCL Virus Watch's longitudinal study of over 46,000 people in England and Wales, show the fall in vaccine hesitancy was consistent across all ethnic groups.
Event - Today
Erin James, University of Sussex's 'Stuart Hall Fellow', to perform at Brighton Festival
Erin James, University of Sussex's 'Stuart Hall Fellow', to perform at Brighton Festival
Innovation - Today
National Grid and University of Manchester pilot drone-mounted electric field sensors for pylon inspections
National Grid and University of Manchester pilot drone-mounted electric field sensors for pylon inspections